https://health-union.com/wp-content/uploads/2020/10/HU-featured-image-Press-Release-100720.jpg
560
1468
Stephen Wilson
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
Stephen Wilson2022-10-24 10:23:462023-05-04 09:52:08Health Union to Present Poster on IBS at ACG’s Annual MeetingPeruse Health Union’s latest news announcements on survey findings, awards, leadership, and more. News media interested in learning more about how Health Union can help them tell the health stories they want to tell can visit our Press Kit and Resource Center for News Media.
https://health-union.com/wp-content/uploads/2020/10/HU-featured-image-Press-Release-100720.jpg
560
1468
Stephen Wilson
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
Stephen Wilson2022-10-24 10:23:462023-05-04 09:52:08Health Union to Present Poster on IBS at ACG’s Annual Meeting
https://health-union.com/wp-content/uploads/2022/10/SMA-IA1-HU@2x.png
560
1800
Stephen Wilson
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
Stephen Wilson2022-10-19 12:31:192023-05-04 09:50:03Survey Reveals Most People with SMA Using New Gene Therapies
https://health-union.com/wp-content/uploads/2022/10/Welcome-feature-image.jpg
714
1872
Stephen Wilson
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
Stephen Wilson2022-10-17 10:03:352022-11-17 09:47:32Health Union Hires Scott Schappell (CRO) & Steve Warker (EVP, Product)
https://health-union.com/wp-content/uploads/2020/10/HU-featured-image-Press-Release-100720.jpg
560
1468
Stephen Wilson
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
Stephen Wilson2022-09-20 09:46:232023-05-04 09:47:18Health Union to Present Myasthenia Gravis Poster at AANEM Annual MeetingHealth Union to Present Poster on IBS at ACG’s Annual Meeting
The research reveals that 40% of survey respondents considered their condition severe and 55% considered their IBS moderate.
Survey Reveals Most People with SMA Using New Gene Therapies
Three-fourths of survey respondents said they currently use an “SMN-enhancing” treatment, while another 19% said they previously used one.
Health Union Hires Scott Schappell (CRO) & Steve Warker (EVP, Product)
These key hirings bring experience and expertise that will enhance and extend the value of Health Union’s business model and offerings.
Health Union to Present Myasthenia Gravis Poster at AANEM Annual Meeting
The aim of Health Union’s research was to determine how using MG-specific community resources may impact patients’ perceptions of their health journey.